1) mid-advanced gynecological carcinoma
中晚期妇科肿瘤
1.
Objective To estimate the clinical effects on the patients with mid-advanced gynecological carcinoma by cytokine-induced killer(CIK) cells .
结论CIK细胞疗法为无法手术、放疗、化疗的中晚期妇科肿瘤患者,提供了一个可以延长生存期,提高生活质量的新方法。
2) Advanced gynecologic cancer
Rg3晚期复发妇科肿瘤
4) advanced cancer
中晚期恶性肿瘤
1.
Combination of kanglaite and radiotherapy in the treatment of advanced cancer patiets.;
康莱特联合放疗治疗中晚期恶性肿瘤的临床研究
2.
Combination of Fufangbanmaojiaonang and radiotherapy in the treatment of advanced cancer
复方斑蝥胶囊联合放疗治疗中晚期恶性肿瘤的临床研究
5) Gynecological Tumor
妇科肿瘤
1.
Research of Osteopontin and Gynecological Tumor;
骨桥蛋白与妇科肿瘤关系的研究
2.
Progress in research on relationship between survivin and gynecological tumors;
Survivin与妇科肿瘤关系的研究进展
3.
Progress in Research on the Relationship between Telomerase and Gynecological Tumor Diognosis and Therapy;
端粒酶与妇科肿瘤诊治的研究进展
补充资料:[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式:C16H16ClN3O3S
分子量:365.5
CAS号:26807-65-8
性质:暂无
制备方法:暂无
用途:用于轻、中度原发性高血压。
分子量:365.5
CAS号:26807-65-8
性质:暂无
制备方法:暂无
用途:用于轻、中度原发性高血压。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条